Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinoma
Open Access
- 18 May 2011
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 17 (S2), S67-S71
- https://doi.org/10.1002/lt.22340
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Management of hepatocellular carcinoma: An updateHepatology, 2011
- Hepatocellular Carcinoma: Novel Molecular Approaches for Diagnosis, Prognosis, and TherapyAnnual Review of Medicine, 2010
- Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisThe Lancet Oncology, 2008
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Met-regulated expression signature defines a subset of human hepatocellular carcinomas with poor prognosis and aggressive phenotypeJCI Insight, 2006
- Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profilingHepatology, 2005
- Resection and Liver Transplantation for Hepatocellular CarcinomaSeminars in Liver Disease, 2005
- Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinomaCancer, 2005
- Prognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinomaBritish Journal of Surgery, 2004
- Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with CirrhosisThe New England Journal of Medicine, 1996